|
Rep. Laura Fine
Filed: 4/19/2018
| | 10000HB4146ham002 | | LRB100 14115 JLS 38393 a |
|
|
1 | | AMENDMENT TO HOUSE BILL 4146
|
2 | | AMENDMENT NO. ______. Amend House Bill 4146 on page 3 by |
3 | | replacing lines 13 through 16 with the following:
|
4 | | " This paragraph (3) does not prohibit a health care |
5 | | plan from removing a brand name drug or changing its |
6 | | preferred or tiered cost-sharing if the plan adds a |
7 | | therapeutically equivalent generic drug (as determined by |
8 | | the United States Food and Drug Administration) if such |
9 | | generic drug was not available on the market at the |
10 | | beginning of the enrollee's plan year if the health care |
11 | | plan does all of the following at least 30 days before |
12 | | making the formulary change: |
13 | | (i) provide general notification of the change in |
14 | | its formulary to current and prospective enrollees; |
15 | | and |
16 | | (ii) provide direct notification to enrollees |
17 | | currently prescribed the drug, including information |
18 | | on the specific drugs involved and steps they may take |